Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Ruber Juan Bravo University Hospital in Madrid has joined the RESILIENCE project in August with the aim of collaborating with us to reduce the prevalence of chronic heart failure in cancer survivors. Dr. Arancha Alonso, hematologist at the Hospital and principal investigator of this center in RESILIENCE believes that “the participation in this trial is […]
